Munro Peacock

Q: What Schools Are Affiliated With Munro Peacock

Munro Peacock is affiliated with the following schools: Indiana University, Georgetown University, Purdue University

Munro Peacock's AcademicInfluence.com Rankings

Munro Peacock

Philosophy

#4485

World Rank

#7019

Historical Rank

Logic

#1925

World Rank

#2797

Historical Rank

philosophy Degrees

Munro Peacock

Biology

#5861

World Rank

#8441

Historical Rank

Molecular Biology

#566

World Rank

#579

Historical Rank

Genetics

#542

World Rank

#618

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Munro Peacock's Degrees

PhD Genetics University of California, Berkeley
Doctorate Medicine University of California, San Francisco

Why Is Munro Peacock Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Munro Peacock's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Common genetic determinants of vitamin D insufficiency: a genome-wide association study (2010) (1177)
Calcium supplementation and increases in bone mineral density in children. (1992) (1071)
A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group. (2000) (1055)
Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture (2012) (1045)
Denosumab in postmenopausal women with low bone mineral density. (2006) (933)
Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. (2002) (758)
Calcium metabolism in health and disease. (2010) (522)
Parent-of-origin specific allelic associations among 106 genomic loci for age at menarche (2014) (511)
Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. (2009) (484)
Thirty new loci for age at menarche identified by a meta-analysis of genome-wide association studies (2010) (477)
Sex steroids and bone mass in older men. Positive associations with serum estrogens and negative associations with androgens. (1997) (450)
Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism. (2005) (422)
Risk factors in calcium stone disease of the urinary tract. (1978) (378)
Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice (2011) (323)
Peak bone mass in young women (1995) (310)
Current issues in the presentation of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. (2014) (305)
The cause of idiopathic calcium stone disease: hypercalciuria or hyperoxaluria? (1980) (302)
Sex steroids, bone mass, and bone loss. A prospective study of pre-, peri-, and postmenopausal women. (1996) (299)
Activity products in stone-forming and non-stone-forming urine. (1968) (294)
Bone mineral density in relation to polymorphism at the vitamin D receptor gene locus. (1994) (274)
Inhibitors of the growth and aggregation of calcium oxalate crystals in vitro. (1973) (247)
Iron modifies plasma FGF23 differently in autosomal dominant hypophosphatemic rickets and healthy humans. (2011) (246)
Genome-wide association study in 79,366 European-ancestry individuals informs the genetic architecture of 25-hydroxyvitamin D levels (2018) (246)
Effect of calcium or 25OH vitamin D3 dietary supplementation on bone loss at the hip in men and women over the age of 60. (2000) (245)
Do variations in hip geometry explain differences in hip fracture risk between japanese and white americans? (1994) (245)
The calcimimetic cinacalcet normalizes serum calcium in subjects with primary hyperparathyroidism. (2003) (239)
Randomized trial of the anti-FGF23 antibody KRN23 in X-linked hypophosphatemia. (2014) (237)
Saturation-inhibition index as a measure of the risk of calcium oxalate stone formation in the urinary tract. (1976) (236)
Reduced Rates of Skeletal Remodeling Are Associated with Increased Bone Mineral Density During the Development of Peak Skeletal Mass (1997) (235)
Geometric structure of the femoral neck measured using dual‐energy X‐ray absorptiometry (1994) (230)
Cinacalcet hydrochloride reduces the serum calcium concentration in inoperable parathyroid carcinoma. (2007) (225)
Calcium retention in relation to calcium intake and postmenarcheal age in adolescent females. (1997) (225)
Presentation of Hypoparathyroidism: Etiologies and Clinical Features. (2016) (223)
Sensitivity of fibroblast growth factor 23 measurements in tumor-induced osteomalacia. (2006) (221)
The effect of high animal protein intake on the risk of calcium stone-formation in the urinary tract. (1979) (219)
Effect of osteoarthritis in the lumbar spine and hip on bone mineral density and diagnosis of osteoporosis in elderly men and women (2007) (218)
Oral calcium carbonate affects calcium but not phosphorus balance in stage 3–4 chronic kidney disease (2012) (213)
Calcium oxalate crystalluria and inhibitors of crystallization in recurrent renal stone-formers. (1972) (212)
Genome screen for QTLs contributing to normal variation in bone mineral density and osteoporosis. (2000) (212)
Osteoporosis in hypogonadal men: role of decreased plasma 1,25-dihydroxyvitamin D, calcium malabsorption, and low bone formation. (1986) (210)
Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. (2009) (199)
Vitamin D receptor gene alleles and osteoporosis: A contrasting view (1995) (193)
Calcium crystalluria in recurrent renal-stone formers. (1969) (193)
Cinacalcet treatment of primary hyperparathyroidism: biochemical and bone densitometric outcomes in a five-year study. (2009) (188)
Relation between serum and urinary calcium with particular reference to parathyroid activity. (1969) (177)
Ethinyl estradiol and norethindrone in the treatment of primary hyperparathyroidism in postmenopausal women. (1986) (169)
Genetics of osteoporosis. (2002) (162)
Meta‐Analysis of Genome‐Wide Scans Provides Evidence for Sex‐ and Site‐Specific Regulation of Bone Mass (2006) (161)
Clinical utility of simultaneous quantitation of 25-hydroxyvitamin D and 24,25-dihydroxyvitamin D by LC-MS/MS involving derivatization with DMEQ-TAD. (2014) (158)
Dairy products do not lead to alterations in body weight or fat mass in young women in a 1-y intervention. (2005) (156)
Early effects of ethinyloestradiol and norethisterone treatment in post-menopausal women on bone resorption and calcium regulating hormones. (1985) (150)
Plasma 25-hydroxy vitamin D concentrations in patients with fractures of the femoral neck. (1979) (150)
NHANES monitoring of serum 25-hydroxyvitamin D: a roundtable summary. (2010) (147)
Linkage of a QTL Contributing to Normal Variation in Bone Mineral Density to Chromosome 11q12–13 (1998) (146)
Calcium oxalate crystalluria and urine saturation in recurrent renal stone-formers. (1971) (139)
Racial differences in bone turnover and calcium metabolism in adolescent females. (2003) (137)
Tumour-induced osteomalacia (2017) (137)
Calcium malabsorption in elderly women with vertebral fractures: evidence for resistance to the action of vitamin D metabolites on the bowel. (1984) (137)
Effect of denosumab on bone mineral density and biochemical markers of bone turnover: six-year results of a phase 2 clinical trial. (2011) (136)
Serum leptin, parathyroid hormone, 1,25-dihydroxyvitamin D, fibroblast growth factor 23, bone alkaline phosphatase, and sclerostin relationships in obesity. (2012) (132)
Large meta-analysis of genome-wide association studies identifies five loci for lean body mass (2017) (127)
Genome Screen for Quantitative Trait Loci Underlying Normal Variation in Femoral Structure (2001) (126)
Prolonged Correction of Serum Phosphorus in Adults With X-Linked Hypophosphatemia Using Monthly Doses of KRN23. (2015) (126)
9 Osteoporosis and osteomalacia (1980) (126)
Parathyroid hormone: sequence, synthesis, immunoassay studies. (1971) (125)
Urinary Acid Mucopolysaccharide Inhibitors of Calcium Oxalate Crystallisation (1976) (125)
Better discrimination of hip fracture using bone density, geometry and architecture (1995) (125)
Two‐Year Clinical Trial of Oral Alendronate Versus Intravenous Pamidronate in Children With Osteogenesis Imperfecta (2005) (123)
Effects of Iron Isomaltoside vs Ferric Carboxymaltose on Hypophosphatemia in Iron-Deficiency Anemia: Two Randomized Clinical Trials. (2020) (122)
Role of kidney in regulation of plasma-calcium. (1969) (121)
Serum markers of bone turnover are increased at six and 18 months after Roux-en-Y bariatric surgery: correlation with the reduction in leptin. (2010) (118)
Vitamin D and hyperparathyroidism in obesity. (2011) (117)
Prolonged heparin therapy in pregnancy causes bone demineralization (1983) (117)
Contrasting microanatomy of idiopathic and corticosteroid-induced osteoporosis. (1989) (117)
Epidemiological risk factors in calcium stone disease. (1980) (116)
Calcium malabsorption in the elderly: the effect of treatment with oral 25‐hydroxyvitamin D3 (1983) (113)
Racial differences in skeletal calcium retention in adolescent girls with varied controlled calcium intakes. (2007) (112)
Dietary changes and the incidence of urinary calculi in the U.K. between 1958 and 1976. (1979) (112)
Neonatal Iron Deficiency Causes Abnormal Phosphate Metabolism by Elevating FGF23 in Normal and ADHR Mice (2014) (112)
Effect of denosumab on bone mineral density and biochemical markers of bone turnover: 8-year results of a phase 2 clinical trial (2012) (109)
Should recurrent calcium oxalate stone formers become vegetarians? (1979) (108)
Cinacalcet HCl reduces hypercalcemia in primary hyperparathyroidism across a wide spectrum of disease severity. (2010) (108)
The decline in vitamin D status with age. (1980) (105)
Cinacalcet reduces serum calcium concentrations in patients with intractable primary hyperparathyroidism. (2009) (104)
Dairy intakes affect bone density in the elderly. (2004) (104)
Age-Related Changes in Serum Undercarboxylated Osteocalcin and its Relationships with Bone Density, Bone Quality, and Hip Fracture (1998) (101)
The genetics of proximal femur geometry, distribution of bone mass and bone mineral density (2005) (101)
Spinal osteoporosis in men. (1989) (100)
Changes in calcium kinetics in adolescent girls induced by high calcium intake. (2000) (100)
Sodium retention in black and white female adolescents in response to salt intake. (2004) (100)
Differences in calcium metabolism between adolescent and adult females. (1995) (100)
The measurement and the meaning of urinary calcium. (1967) (99)
Contribution of the LRP5 Gene to Normal Variation in Peak BMD in Women (2004) (96)
PLASMA 25-HYDROXYVITAMIN D IN PREGNANT ASIAN WOMEN AND THEIR BABIES (1979) (96)
ApaI, BsmI, EcoRV and TaqI polymorphisms at the human vitamin D receptor gene locus in Caucasians, blacks and Asians. (1993) (95)
Effects of vitamin D supplementation in older African American women. (2013) (95)
Protection From Glucocorticoid‐Induced Osteoporosis by Anti‐Catabolic Signaling in the Absence of Sost/Sclerostin (2016) (94)
NON‐AUTONOMY OF HORMONE SECRETION IN PRIMARY HYPERPARATHYROIDISM (1972) (93)
Tubular reabsorption of calcium in normal and hypercalciuric subjects (1968) (89)
Studies on the prevalence and epidemiology of urinary stone disease in men in Leeds. (1983) (89)
Vitamin D status and calcium metabolism in adolescent black and white girls on a range of controlled calcium intakes. (2008) (88)
Hypercalciuria and calcium stone disease (1972) (87)
Differences in calcium kinetics between adolescent girls and young women. (1996) (85)
Control of Bone Anabolism in Response to Mechanical Loading and PTH by Distinct Mechanisms Downstream of the PTH Receptor (2017) (84)
The effect of soy protein and soy isoflavones on calcium metabolism in postmenopausal women: a randomized crossover study. (2005) (84)
Meta‐analysis of genome‐wide studies identifies WNT16 and ESR1 SNPs associated with bone mineral density in premenopausal women (2013) (84)
Intravenous pamidronate treatment of children under 36 months of age with osteogenesis imperfecta. (2004) (84)
Calcaneal ultrasonic measurements discriminate hip fracture independently of bone mass (1995) (83)
Osteomalacia and osteoporosis in femoral neck fracture. (1990) (82)
Effects of Calcium and Vitamin D Insufficiency on the Skeleton (1998) (81)
Effects of nitric oxide synthase inhibitors on bone formation in rats. (1997) (80)
Soluble maize fibre affects short-term calcium absorption in adolescent boys and girls: a randomised controlled trial using dual stable isotopic tracers (2014) (79)
Impact of exercise on bone health and contraindication of oral contraceptive use in young women. (2001) (79)
Quantification of Biochemical Markers of Bone Turnover by Kinetic Measures of Bone Formation and Resorption in Young Healthy Females (1997) (79)
Antiresorptive effects of phytoestrogen supplements compared with estradiol or risedronate in postmenopausal women using (41)Ca methodology. (2009) (78)
Bone Mass and Structure at the Hip in Men and Women over the Age of 60 Years (1998) (78)
Differences in muscle endurance and recovery between fallers and nonfallers, and between young and older women. (1997) (77)
Genome-wide association study of bone mineral density in premenopausal European-American women and replication in African-American women. (2010) (77)
Adolescent nutrition in the prevention of postmenopausal osteoporosis. (1999) (76)
Variability in Skeletal Mass, Structure, and Biomechanical Properties Among Inbred Strains of Rats (2001) (76)
Glucocorticoids Induce Bone and Muscle Atrophy by Tissue-Specific Mechanisms Upstream of E3 Ubiquitin Ligases (2017) (76)
A prospective trial of the effect of vitamin D supplementation on metacarpal bone loss in elderly women. (1985) (76)
Seasonal variations in the composition of urine in relation to calcium stone-formation. (1975) (76)
Human ALOX12, but Not ALOX15, Is Associated With BMD in White Men and Women (2005) (75)
A Randomized Trial of Vitamin D3 Supplementation in Children: Dose-Response Effects on Vitamin D Metabolites and Calcium Absorption (2013) (75)
New techniques for the separation and measurement of the calcium fractions of normal human serum. (1968) (73)
Sex-specific and non-sex-specific quantitative trait loci contribute to normal variation in bone mineral density in men. (2005) (73)
Importance of Dietary Calcium in the Definition of Hypercalciuria (1967) (72)
Urinary excretion of calcium and creatinine in relation to age and body weight in normal subjects and patients with renal calculus. (1970) (72)
TURNOVER OF ENDOGENOUS PARATHYROID HORMONE IN UREMIC PATIENTS AND THOSE UNDERGOING HEMODIALYSIS (1972) (71)
Calcium absorption efficiency and calcium requirements in children and adolescents. (1991) (70)
Sibling pair linkage and association studies between bone mineral density and the insulin-like growth factor I gene locus. (1999) (70)
Rates of Growth and Loss of Bone Mineral in the Spine and Femoral Neck in White Females (1999) (69)
Osteomalacia in Paget's disease treated with short term, high dose sodium etidronate. (1986) (69)
Development and optimization of an LC-MS/MS-based method for simultaneous quantification of vitamin D2 , vitamin D3 , 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3. (2011) (69)
Fat oxidation and its relation to serum parathyroid hormone in young women enrolled in a 1-y dairy calcium intervention. (2005) (68)
Renal Effects of Calcitonin (1970) (67)
The pattern of urinary stone disease in Leeds and in the United Kingdom in relation to animal protein intake during the period 1960-1980. (1982) (67)
The effect of oestrogens on the response of bone to parathyroid hormone in vitro. (1972) (66)
Primary hyperparathyroidism and the kidney: biochemical and clinical spectrum. (2002) (66)
Fluoride Treatment Increased Serum IGF-1, Bone Turnover, and Bone Mass, but Not Bone Strength, in Rabbits (1997) (66)
Effect of intestinal surgery on the risk of urinary stone formation. (1981) (65)
Racial differences in calcium retention in response to dietary salt in adolescent girls. (2005) (65)
Polymorphism at an Sp1 Binding Site of COL1A1 and Bone Mineral Density in Premenopausal Female Twins and Elderly Fracture Patients (1999) (65)
Action of 1alpha-hydroxy vitamin D3 on calcium absorption and bone resorption in man. (1974) (64)
Impact of equol-producing capacity and soy-isoflavone profiles of supplements on bone calcium retention in postmenopausal women: a randomized crossover trial. (2015) (64)
Bone loss at the femoral neck in premenopausal white women: effects of weight change and sex-hormone levels. (2002) (63)
Renal impairment and its effects on calcium metabolism in elderly women. (1984) (63)
Dietary calcium intake protects women consuming oral contraceptives from spine and hip bone loss. (2005) (63)
Race and sex differences in bone mineral density and geometry at the femur. (2009) (60)
COMPARISON OF THE EFFECTS OF ORAL AND TRANSDERMAL OESTRADIOL ADMINISTRATION ON OESTROGEN METABOLISM, PROTEIN SYNTHESIS, GONADOTROPHIN RELEASE, BONE TURNOVER AND CLIMACTERIC SYMPTOMS IN POSTMENOPAUSAL WOMEN (1989) (58)
Soluble corn fiber increases bone calcium retention in postmenopausal women in a dose-dependent manner: a randomized crossover trial. (2016) (58)
Calcium retention in adolescent boys on a range of controlled calcium intakes. (2006) (58)
Cytokine production and surface antigen expression by peripheral blood mononuclear cells in postmenopausal osteoporosis (1993) (58)
Soy isoflavones do not affect bone resorption in postmenopausal women: a dose-response study using a novel approach with 41Ca. (2007) (58)
Assay of plasma 25-hydroxy vitamin D. (1976) (57)
Effect of 1‐Year Dairy Product Intervention on Fat Mass in Young Women: 6‐Month Follow‐up (2006) (56)
Dialysate aluminium concentration and renal bone disease. (1982) (56)
Confirmation of linkage to chromosome 1q for peak vertebral bone mineral density in premenopausal white women. (2004) (55)
The role of affluence and diet in the genesis of calcium-containing stones (1978) (55)
Peak bone mineral density at the hip is linked to chromosomes 14q and 15q (2004) (55)
Seasonal Variations in Urinary Excretion of Calcium (1974) (55)
Velcalcetide (AMG 416), a novel peptide agonist of the calcium-sensing receptor, reduces serum parathyroid hormone and FGF23 levels in healthy male subjects (2013) (54)
Burosumab for the Treatment of Tumor‐Induced Osteomalacia (2020) (54)
Effect of calcium administration and deprivation on serum and urine calcium in stone-forming and control subjects. (1968) (54)
Difference in bone mass between black and white American children: attributable to body build, sex hormone levels, or bone turnover? (2003) (53)
Inhibition of caspase-9 reduces chondrocyte apoptosis and proteoglycan loss following mechanical trauma. (2006) (52)
Prevalence of urinary stone disease in vegetarians. (1982) (52)
Racial differences in cortical bone and their relationship to biochemical variables in Black and White children in the early stages of puberty (2013) (52)
Calcium absorption from apple and orange juice fortified with calcium citrate malate (CCM). (1996) (51)
Calcium retention estimated from indicators of skeletal status in adolescent girls and young women. (1996) (51)
Polymorphisms in the estrogen receptor beta (ESR2) gene are associated with bone mineral density in Caucasian men and women. (2005) (50)
A comparison of the effects of the calcitonins, steroid hormones and thyroid hormones on the response of bone to parathyroid hormone in tissue culture. (1975) (49)
[Pathogenesis of urolithiasis]. (1984) (48)
THE EFFECT OF TRANSDERMAL OESTROGEN ON BONE, CALCIUM‐REGULATING HORMONES AND LIVER IN POSTMENOPAUSAL WOMEN (1986) (47)
Predictors of calcium retention in adolescent boys. (2008) (47)
Phosphate Metabolism in Health and Disease (2020) (46)
Systemic and Cerebral Iron Homeostasis in Ferritin Knock-Out Mice (2015) (46)
Daily supplementation with 25 μg cholecalciferol does not increase calcium absorption or skeletal retention in adolescent girls with low serum 25-hydroxyvitamin D. (2010) (45)
Calcium Requirements and Metabolism in Chinese-American Boys and Girls (2010) (44)
Effect of four monthly doses of a human monoclonal anti-FGF23 antibody (KRN23) on quality of life in X-linked hypophosphatemia (2016) (44)
A Comparison of Oral and Intravenous Bisphosphonate Therapy for Children with Osteogenesis Imperfecta (2005) (43)
Genetic Variants Associated with Circulating Parathyroid Hormone. (2017) (43)
Hypomagnesaemia after small bowel resection: Treatment with 1 α‐hydroxylated vitamin D metabolites (1984) (43)
Staining of the calcification front in human bone using contrasting fluorochromes in vitro. (1984) (43)
Sib pair linkage and association studies between bone mineral density and the interleukin-6 gene locus. (2000) (42)
Linkage of Structure at the Proximal Femur to Chromosomes 3, 7, 8, and 19 (2003) (42)
When should patients with symptomatic urinary stone disease be evaluated metabolically? (1984) (41)
Plasma 1,25(OH)2 vitamin D measured by radioimmunoassay and cytosol radioreceptor assay in normal subjects and patients with primary hyperparathyroidism and renal failure. (1980) (41)
Usefulness of beta 2-transferrin assay in the detection of cerebrospinal fluid leaks following head injury. (1992) (40)
Renal tubular acidosis of pyelonephritis with renal stone disease. (1968) (40)
Pharmacokinetics and pharmacodynamics of a human monoclonal anti‐FGF23 antibody (KRN23) in the first multiple ascending‐dose trial treating adults with X‐linked hypophosphatemia (2015) (39)
Safety and efficacy of pulse and daily calcitriol in patients on CAPD: a randomized trial. (1998) (39)
Sex-specific quantitative trait loci contribute to normal variation in bone structure at the proximal femur in men. (2005) (38)
Quantitative analysis of calcium-containing urinary calculi. (1969) (38)
The effect of dairy intake on bone mass and body composition in early pubertal girls and boys: a randomized controlled trial. (2017) (38)
Purification of plasma vitamin D metabolites for radioimmunoassay. (1980) (37)
A comparison of the urinary excretion of bone resorptive products in white and black children. (1996) (37)
Dose dependent response of symptoms, pituitary, and bone to transdermal oestrogen in postmenopausal women. (1986) (37)
Safety and Efficacy of 5 Years of Treatment With Recombinant Human Parathyroid Hormone in Adults With Hypoparathyroidism (2019) (36)
Serum fibroblast growth factor 23, serum iron and bone mineral density in premenopausal women. (2016) (36)
Magnesium kinetics in adolescent girls determined using stable isotopes: effects of high and low calcium intake. (1997) (35)
Parathyroid hormone is associated with decreased fat mass in young healthy women (2006) (35)
A Multicentre Trial to Evaluate Three Treatments for Recurrent Idiopathic Calcium Stone Disease — A Preliminary Report (1985) (34)
Adiposity, Insulin Resistance, and Bone Mass in Children and Adolescents (2018) (34)
Racial differences in potassium homeostasis in response to differences in dietary sodium in girls. (2010) (33)
Local action of oral 1,25-dihydroxycholecalciferol on calcium absorption in osteoporosis. (1987) (33)
Urolithiasis: Etiology · Diagnosis (1985) (32)
Hypercalcaemia due to sarcoidosis corrects with bisphosphonate treatment. (1986) (32)
Common genetic determinants of vitamin D insufficiency (2011) (32)
Inhibition of calcium oxalate crystallisation by pentosan polysulphate in control subjects and stone formers. (1984) (32)
Glucocorticoid Excess in Bone and Muscle (2018) (31)
Magnesium retention from metabolic-balance studies in female adolescents: impact of race, dietary salt, and calcium. (2013) (31)
The vitamin D analogue 2MD increases bone turnover but not BMD in postmenopausal women with osteopenia: Results of a 1‐year phase 2 double‐blind, placebo‐controlled, randomized clinical trial (2011) (31)
Heritability of Changes in Bone Size and Bone Mass With Age in Premenopausal White Sisters (2006) (31)
Sibling pair linkage and association studies between peak bone mineral density and the gene locus for the osteoclast-specific subunit (OC116) of the vacuolar proton pump on chromosome 11p12-13. (2002) (30)
Nrf2 regulates mass accrual and the antioxidant endogenous response in bone differently depending on the sex and age (2017) (30)
Long term study of the effect of rifampicin and isoniazid on vitamin D metabolism. (1985) (29)
The effect of parathyroid hormone on the uptake and release of calcium by bone in tissue culture. (1972) (29)
Genetic Variants Associated with Circulating Fibroblast Growth Factor 23. (2018) (28)
The Main Risk Factor for Calcium Oxalate Stone Disease in Man: Hypercalciuria or Mild Hyperoxaluria? (1981) (28)
Renal Excretion of Calcium (1988) (28)
Disentangling the genetics of lean mass. (2019) (28)
The effect of ethane-1-hydroxy-1,1-diphosphonate (EHDP) on calcium oxalate crystalluria in recurrent renal stoneformers. (1974) (28)
Calcium, dairy products, and energy balance in overweight adolescents: a controlled trial. (2011) (27)
Obesity augments calcium-induced increases in skeletal calcium retention in adolescents. (2011) (27)
Spinal osteoporosis in men (1989) (27)
Bone mineral density variation in men is influenced by sex-specific and non sex-specific quantitative trait loci. (2009) (27)
Interpretation of bone mass determinations as they relate to fracture: Implications for asymptomatic primary hyperparathyroidism (1991) (27)
Effect of Systemic Iron Overload and a Chelation Therapy in a Mouse Model of the Neurodegenerative Disease Hereditary Ferritinopathy (2016) (27)
Association of adenovirus 36 infection with adiposity and inflammatory-related markers in children. (2014) (26)
A stochastic model of age-related bone loss and fractures. (1985) (26)
Primary hyperparathyroidism associated with primary hyperaldosteronism. (1983) (26)
Associations between genetic variants and the effect of letrozole and exemestane on bone mass and bone turnover (2015) (25)
Meta‐Analysis of Genomewide Association Studies Reveals Genetic Variants for Hip Bone Geometry (2019) (25)
Effect of dialysate calcium concentration on bone disease in patients on hemodialysis. (1976) (25)
Tumoral calcinosis: a manifestation of extreme metastatic calcification occurring with 1, alpha-hydroxycholecalciferol therapy. (1977) (24)
False Positive Rates in Association Studies as a Function of Degree of Stratification (2004) (24)
Calcium absorption in children estimated from single and double stable calcium isotope techniques. (1989) (24)
Vitamin D metabolism in women with femoral neck fracture. (1987) (23)
The architecture of cancellous and cortical bone in femoral neck fracture. (1990) (23)
Vitamin D receptor genotype and bone mineral density (1995) (22)
Vitamin D Supplementation Does Not Impact Insulin Resistance in Black and White Children. (2016) (22)
Effect of Hesperidin With and Without a Calcium (Calcilock) Supplement on Bone Health in Postmenopausal Women. (2016) (22)
Replication of Previous Genome-wide Association Studies of Bone Mineral Density in Premenopausal American Women (2010) (22)
Dose dependent response of symptoms, pituitary, and bone to transdermal oestrogen in postmenopausal women. (1987) (22)
Clinical and metabolic aspects of urinary stone disease in Leeds. (1980) (21)
A bioassay for parathyroid hormone using whole mouse calvaria in tissue culture. (1974) (21)
Twenty-Four-Hour Urine Phosphorus as a Biomarker of Dietary Phosphorus Intake and Absorption in CKD: A Secondary Analysis from a Controlled Diet Balance Study. (2018) (20)
Effect of vitamin D metabolites on proximal muscle weakness (1977) (19)
Soft tissue calcification in the Ossabaw miniature pig: experimental and kinetic modeling studies (2012) (19)
Novel homozygous mutations in the osteoprotegerin gene TNFRSF11B in two unrelated patients with juvenile Paget's disease. (2014) (19)
Insulin Resistance and the IGF‐I‐Cortical Bone Relationship in Children Ages 9 to 13 Years (2017) (18)
Bone turnover is not influenced by serum 25-hydroxyvitamin D in pubertal healthy black and white children. (2012) (18)
Phosphate treatment of recurrent calcium stone disease. (1982) (18)
Calcium absorption in the elderly (1975) (17)
Comparison of serum 25-OH vitamin D concentrations in rheumatoid arthritis and osteoarthrosis. (1980) (17)
Velocities of Bone Mineral Accrual in Black and White American Children (2010) (17)
Hypercalcaemia and calcium homeostasis (1980) (16)
Hypoparathyroidism and the Kidney. (2018) (16)
The Apparent Relation between Plasma 25-Hydroxyvitamin D and Insulin Resistance is Largely Attributable to Central Adiposity in Overweight and Obese Adults. (2015) (16)
Relative importance of renal failure and increased bone resorption in the hypercalcaemia of myelomatosis. (1981) (16)
VITAMIN D RESISTANT HYPOPHOSPHATAEMIC OSTEOMALACIA: TREATMENT WITH la–HYDROXYVITAMIN D3 (1977) (16)
Calcium Excretion and Hypercalciuria (1976) (15)
Life-threatening hypercalcemia associated with primary hyperparathyroidism during pregnancy: case report and review of literature. (1999) (15)
Association of Adenylate Cyclase 10 (ADCY10) Polymorphisms and Bone Mineral Density in Healthy Adults (2009) (15)
Peritoneal dialysis in the management of severe hypercalcaemia. (1980) (14)
Factors influencing the intestinal absorption of calcium and phosphorus following renal transplantation. (1980) (14)
The Effect of an Increased Intake of Various Constituents of a High Animal Protein Diet on the Risk of Calcium Oxalate Stone Formation in Men (1985) (14)
Should Recurrent Calcium Oxalate Stone Formers Eat Less Animal Protein (1981) (14)
Effect of chronic administration of ammonium sulfate on phosphatic stone recurrence. (1987) (14)
The Saturation of Urine in Recurrent, Idiopathic Calcium Stone-Formers (1976) (14)
BONE DISEASE AND H YPERP AR ATH YROI DISM IN CHRONIC RENAL FAILURE: THE EFFECT OF lα‐HYDROXYVITAMIN D3 (1977) (14)
Polymorphisms in the bone morphogenetic protein 2 (BMP2) gene do not affect bone mineral density in white men or women (2006) (13)
OF EPIDEMIOLOGICAL FACTORS IN THE GENESIS OF CALCIUM STONES (1981) (13)
Epidemiological Risk Factors in Calcium Stone-Formation (1979) (12)
The Prevalence of Urinary Stone Disease in Practising Vegetarians (1982) (12)
Thoracic phosphaturic mesenchymal tumors causing oncogenic osteomalacia (2013) (12)
Vitamin D status and resistance exercise training independently affect glucose tolerance in older adults. (2013) (12)
Stone disease of the urinary tract. (1981) (12)
Effect of Oral Orthophosphate on Calcium Crystalluria in Stone-Formers (1976) (12)
Sodium pentosan polysulphate as a polyanionic inhibitor of calcium oxalate crystallization in vitro and in vivo. (1985) (12)
Association studies of ALOX5 and bone mineral density in healthy adults (2008) (12)
Dietary calcium requirements do not differ between Mexican-American boys and girls. (2014) (11)
The vitamin D metabolites in the pathogenesis and management of osteoporosis. (1981) (11)
Effect of recombinant human growth hormone on adreno-cortical function, and on sodium and potassium homeostasis. (1993) (11)
Hypogammaglobulinaemia with Whipple's disease (1973) (10)
OR13-1 Burosumab Improves the Biochemical, Skeletal, and Clinical Symptoms of Tumor-Induced Osteomalacia Syndrome (2019) (10)
Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche DTU Orbit (05/11/2017) (2014) (10)
Effect of Calcium Carbonate Particle Size on Calcium Absorption and Retention in Adolescent Girls (2011) (10)
PLASMA 1,25(OH)2 VITAMIN D CONCENTRATIONS IN NUTRITIONAL OSTEOMALACIA (1979) (10)
The action of two metabolites of vitamin D3; 25,26‐dihydroxycholecalciferol (25,26(OH)2D3) and 24,25‐dihydroxycholecalciferol (24,25(OH)2D3)on bone resorption (1976) (10)
SIBLING family genes and bone mineral density: association and allele-specific expression in humans. (2014) (10)
Associations among osteocalcin, leptin and metabolic health in children ages 9–13 years in the United States (2017) (9)
Proceedings: Inhibitory effect of 24,25-dihydroxycholecalciferol on parathyroid hormone secretion in the goat. (1975) (9)
Calcium-41: a technology for monitoring changes in bone mineral (2017) (9)
Physiology of Vitamin D, Calcium, and Phosphate Absorption (2014) (9)
The effects of vitamin D metabolites and their analogues on the secretion of parathyroid hormone (1975) (9)
Renal stones and sodium. (1967) (9)
The Effect of “High Fibre Biscuits” on Urinary Risk Factors for Stone Formation (1985) (9)
Acute effects of saline, calcitonin, and hydrocortisone on plasma calcium in vitamin D intoxication. (1979) (8)
Biochemical evidence of vitamin D deficiency in pregnant Asian women. (1981) (8)
Diagnosis of Asymptomatic Primary Hyperparathyroidism : Proceedings of the Society (2009) (8)
Erratum: Large meta-analysis of genome-wide association studies identifies five loci for lean body mass (2017) (8)
Skeletal Protection and Promotion of Microbiome Diversity by Dietary Boosting of the Endogenous Antioxidant Response (2020) (8)
Primary Hyperparathyroidism and the Kidney (2015) (8)
Statement from a Workshop on Asymptomatic Primary Hyperparathyroidism : A Perspective for the 21 st Century (2002) (7)
THE MANAGEMENT OF H Y POP A R ATH YRO ID ISM WITH lα‐HYDROXYVITAMIN D3 (1977) (7)
A comparison of the effect of sorbitol and glucose on calcium absorption in postmenopausal women. (1986) (7)
Identification of a Linkage Disequilibrium Block in Chromosome 1q Associated With BMD in Premenopausal White Women (2008) (7)
Review of risk factors in calcium oxalate urolithiasis (1983) (7)
PROPHYLACTIC 1α‐HYDROXYVITAMIN D3 THERAPY IN HAEMODIALYSIS PATIENTS (1977) (7)
Calcium Intake and Age Influence Calcium Retention in Adolescence (1998) (7)
Erratum to Fluoride Treatment Increased Serum IGF-1 Bone Turnover, and Bone Mass, But Not Bone Strength, in Rabbits (1997) (7)
Characteristics of antisera to antigenic forms of 1,25-dihydroxycholecalciferol. (1986) (7)
The mechanisms of hypercalciuria are unnecessary for treatment of recurrent renal calcium stone formers. (1982) (7)
Phosphorus Balance in Adolescent Girls and the Effect of Supplemental Dietary Calcium (2018) (7)
BsmI polymorphism at the parathyroid hormone receptor locus (PTHR) in three populations. (1993) (7)
Urinary tract stone disease. (1979) (7)
Thyrotoxicosis presenting as fracture of femoral neck. (1982) (7)
Purification of vitamin D binding protein from human plasma using high performance liquid chromatography. (1986) (7)
Are scintigrams of the spine useful in vertebral osteoporosis? (1986) (7)
THE ROLE OF THE KIDNEY IN THE REGULATION OF PLASMA CALCIUM (1971) (6)
Phosphate Treatment of Idiopathic Calcium Stone Disease (1981) (6)
The Origin of Metabolic Abnormalities in Primary Calcium Stone Disease — Natural or Unnatural Selection? (1985) (6)
Osteoporosis and osteomalacia. (1980) (6)
Risk Factors in stone-formation (1977) (6)
X-linked hypophosphatemia: Understanding and management (2010) (6)
Serum 25‐Hydroxyvitamin D and Intact Parathyroid Hormone Influence Muscle Outcomes in Children and Adolescents (2018) (6)
Senile and postmenopausal osteoporosis. (1984) (6)
The effect of hydrochlorothiazide administration on serum and urinary calcium in normal, hypoparathyroid and hyperparathyroid subjects. Studies on mechanisms. (1971) (6)
Acute and long-term kidney function after parathyroidectomy for primary hyperparathyroidism. (2020) (5)
Vitamin D metabolites in post‐menopausal women and their relationship to the myopathic electromyogram (1983) (5)
Development and optimization of an LC-MS / MS-based method for simultaneous quantification of vitamin D 2 , vitamin D 3 , 25-hydroxyvitamin D 2 and 25-hydroxyvitamin D 3 (2016) (5)
Age-related bone loss and fractures (1985) (5)
Epidemiological Studies on Urinary Stone Disease in Men in Leeds (1984) (5)
CLCN7 polymorphisms and bone mineral density in healthy premenopausal white women and in white men. (2008) (5)
The effect of plasma phosphate on the action of 1alphaOHD3 in haemodialysis patients. (1977) (5)
The action of 1alphahydroxy vitamin D3 and phosphate supplements in hypophosphataemic osteomalacia. (1977) (5)
Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. (2002) (4)
THE EFFECT OF E THANE-1-HYDR OXY-1,l- DIPHOSPHONATE (EHDP) ON CALCIUM OXALATE FORMERS CRYSTALLURIA IN RECURRENT RENAL STONE- (1974) (4)
Urinary Stone Formation in Bowel Disease (1981) (4)
Metabolic and biochemical risk factors in renal stone disease. (1984) (4)
Pharmacokinetics and pharmacodynamics of a human monoclonal anti-FGF23 antibody (KRN23) after ascending single-dose administration in patients with X-linked hypophosphatemia (2014) (4)
Bone disease and hyperparathyroidism in chronic renal failure: the effect of 1alpha-hydroxyvitamin D3. (1977) (4)
OR30-1 Safety and Efficacy of Recombinant Human Parathyroid Hormone 1-84 for the Treatment of Adults with Chronic Hypoparathyroidism: Six-Year Results of the RACE Study (2019) (4)
Asymptomatic hyperparathyroidism. (1971) (4)
Calcium (2019) (4)
Serum calcium concentration is maintained when bone resorption is suppressed by osteoprotegerin in young growing male rats. (2018) (4)
Whole egg consumption and cortical bone in healthy children (2018) (3)
Institution and Management of a Stone Clinic (1985) (3)
Author response for "Burosumab for the Treatment of Tumor-Induced Osteomalacia" (2020) (3)
Hypercalcaemia. Management. (1984) (3)
Microanatomical and histological changes associated with trabecular bone loss with aging and in osteoporosis (1985) (3)
Clinical effects of calcimimetics in hyperparathyroidism. (2004) (3)
1-Alpha-hydroxy vitamin D in dialysis bone disease: radiological changes after 6 and 12 months of treatment. (1982) (3)
The pattern of urinary stone disease in Leeds during the period 1960–1980 (1982) (3)
Twenty-Four-Hour Urine Phosphorus as a Biomarker of Dietary Phosphorus Intake and Absorption in CKD (2018) (3)
Skeletal Changes Across the Life Span (2019) (3)
Five-year efficacy and safety of recombinant human parathyroid hormone 1-84 (rhPTH[1-84]) for the treatment of adults with chronic hypoparathyroidism: analysis from the open-label race study (2018) (3)
Plasma 1,25(OH)2D in Idiopathic and Hyperparathyroid Stone-Formers (1981) (3)
The effect of oestrogens on parathyroid hormone mediated bone resorption in tissue culture. (1972) (3)
OR13-3 Effects of Iron Isomaltoside versus Ferric Carboxymaltose on Hormonal Control of Phosphate Homeostasis: The PHOSPHARE-IDA04/05 Randomized Controlled Trials (2019) (3)
Proceedings: Effect of vitamin D and its metabolites on bone in tissue culture. (1974) (3)
Recombinant human parathyroid hormone (rhPTH[1-84], parathyroid hormone rDNA) improves hypercalciuria in patients with hypoparathyroidism: 3-year analysis from RACE study (2017) (3)
Long-term Burosumab Administration Is Safe and Effective in Adults With X-linked Hypophosphatemia (2022) (2)
Racial Differences in Cortical Bone Mass, Size and Estimated Strength at the Tibial Diaphysis in Early Pubertal Children (2012) (2)
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 50-1981. A 76-year-old woman with intermittent hypercalcemia. (1981) (2)
Hypogonadism and osteoporosis (1983) (2)
Genome-wide association study of serum iron phenotypes in premenopausal women of European descent. (2016) (2)
Effect of corticosteroid therapy on plasma 1,25-dihydroxy vitamin D levels (1981) (2)
Calcium absorption efficiency and calcium requirements in children and ,2 (1991) (2)
Clinical Manipulation of Urinary GAGS — A New Method of Stone Prevention (?) (1985) (2)
Calcium retention as a function of calcium intake in Asian adolescents (2007) (2)
Proximal myopathy and the role of vitamin D (1979) (2)
Validation of urinary calcium isotope excretion from bone for screening anabolic therapies for osteoporosis (2014) (2)
Effect of Hesperidin with and without a Nutrient Supplement on Bone Ca Retention in Post‐menopausal Women Using 41Ca Technology (2015) (2)
The treatment of proximal myopathy with 1,25-dihydroxyvitamin D3 or its synthetic analogue 1α hydroxyvitamin D3 in various endocrinological diseases (1977) (2)
Anatomical Localization of Urinary Risk Factors of Calcium Oxalate Stone Formation (1985) (2)
Relationship of calcium intake and calcium retention in adolescent boys. (2003) (1)
Biomarkers of bone metabolism and bone loss in relation to estrogen status, race and osteoporosis (1992) (1)
Calcium Absorption and Plasma 25-Hydroxy-Vitamin D in Elderly Women after Oral 25-Hydroxy-Vitamin D3 (1980) (1)
Inheritance of calcium absorption (1992) (1)
Spine and Hip Bone Loss Dietary Calcium Intake Protects Women Consuming Oral Contraceptives From (2005) (1)
Effect of oral 1,25-hydroxycholecalciferol and 1α-hydroxycholecalciferol on plasma 1,25-dihydroxy vitamin D concentrations in normal subjects and patients with disorders of calcium metabolism (1980) (1)
Moderate Consumption of Freeze-dried Blueberry Powder Increased Net Bone Calcium Retention in Healthy Postmenopausal Women: A Randomized Crossover Trial (2020) (1)
Blueberry containing diets protect from bone loss induced by sex steroid deficiency differently depending on sex and by mechanisms independent of canonical sex steroid receptor signaling (2018) (1)
Bone resorption in postmenopausal women using Ca-41 technology. (2003) (1)
Reply to: Burosumab for Tumor‐Induced Osteomalacia: not Enough of a Good Thing (2021) (1)
The significance of crystalluria in renal stone formation. (1969) (1)
Comparison of the Biological Activity of 25Ohd3and 24, 25(Oh)2D3 (1984) (1)
Assessment of Quality of Life Data After 4 Monthly S.C. Doses of a Human Monoclonal Anti-Fibroblast Growth Factor 23 Antibody (KRN23) in Adults with X-linked Hypophosphatemia (2014) (1)
Recombinant human parathyroid hormone 1-84 for the treatment of adults with chronic hypoparathyroidism: Six-year safety and efficacy results of the RACE study (2019) (1)
Effect of cysteine on the biological and immunological activity of human and bovine parathyroid hormone. (1973) (1)
Biochemical Changes Following Parathyroidectomy (1972) (1)
Treatment of vitamin D resistant hypophosphataemic osteomalacia with 1α-hydroxy vitaminD3 (1976) (1)
Hyperparathyroid and Hypoparathyroid Bone Disease (1993) (1)
Hypogammaglobulinaemia withWhipple's disease (1973) (1)
The management of hypoparathyroidism with 1alpha-hydroxyvitamin D3. (1977) (1)
PROGESTAGEN PLUS CYCLICAL OESTROGEN FOR POSTMENOPAUSAL BONE LOSS (1985) (1)
OR29-06 Burosumab Improves Biochemical, Skeletal, and Clinical Features of Tumor-Induced Osteomalacia Syndrome (2020) (1)
Malabsorption of calcium - steroid induced osteoporosis (1982) (0)
Vitamin D supplementation and insulin sensitivity in early pubertal children: results from the randomized controlled GAPI trial (2012) (0)
Role of Vitamin D in the Epidemiology of Femoral Neck Fracture (1980) (0)
The rationale of phosphate treatment in calcium stone disease (1978) (0)
Early effects of sex steroids on calcium metabolism and patients with primary hyperparathyroidism (1983) (0)
Staining of the calcification front of human bone in vitro with fluorochromes customarily used as labels in vivo (1984) (0)
A randomized, double-blind, placebo-controlled, ascending, single-dose study of a human monoclonal anti-FGF23 antibody (KRN23) in X-linked hypophosphatemia (2014) (0)
Evidence for Resistance to 25 Hydroxy Vitamin D3 in the Malabsorption of Calcium of Elderly Osteoporotic Women (1982) (0)
EFFECT OF EXERCISE INTERVENTION AND AGE ON TOTAL BODY BONE MINERAL CONTENT IN YOUNG WOMEN 949 (1996) (0)
Pharmacokinetics and Pharmacodynamics of a Human Monoclonal Anti-Fibroblast Growth Factor 23 Antibody (KRN23) Following 4 Month Intra-Dose Escalation in Adults with X-Linked Hypophosphatemia (2014) (0)
Progesterone and medroxyprogesterone acetate do not reduce postmenopausal bone loss (1986) (0)
The effect of soy protein and soy isoflavones on calcium metabolism in postmenopausal women: a randomized crossover study 1–3 (2005) (0)
Calcium retention in Mexican American adolescents on a range of controlled calcium intakes (2013) (0)
Corticosteroid osteoporosis: Effect of 25 hydroxyvitamin D on plasma 1,25 dihydroxyvitamin D and calcium absorption (1982) (0)
Vitamin D and Calcium Dietary Supplements in the Elderly (1998) (0)
Development and validation of a new LC‐MS/MS method for simultaneous detection and quantification of Vitamin D related metabolites (2009) (0)
The effect of intramuscular and intravenous administration of calcitonin on bone resorption in osteoporosis (1985) (0)
Pharmacokinetics and pharmacodynamics of a human monoclonal anti-FGF23 antibody (KRN23) in the first multiple ascending-dose trial treating adults with X-linked hypophosphatemia: The Journal of Clinical Pharmacology (2015) (0)
Skeletal remodeling and increasing bone mineral density (BMD) during childhood (2006) (0)
Differences between Leeds fractures and London fractures? (1979) (0)
The influence of denosumab on one mineral densityand biochemical markers of bone remodeling: results of 6-year phase ii trial (2011) (0)
ORAL CALCIDIOL INCREASES SERUM CALCITRIOL: ASSAY ARTIFACTS WITH LOW PRESSURE PURIFICATION (1991) (0)
OR13-1 Long-Term Burosumab Therapy Provides Sustained Benefit in Patients with Tumor-Induced Osteomalacia: End of Study Findings From the Pivotal Phase 2 Study (2022) (0)
Treatment of vitamin D resistant hypophosphataemic osteomalacia with 1alpha-hydroxy vitamin D3. (1977) (0)
Fractures and Dislocations: Thyrotoxicosis presenting as fracture of femoral neck (1983) (0)
The Effects of 8 Years of Continuous Denosumab Treatment on Bone Mineral Density and Biochemical Markers of Bone Turnover in a Phase 2 Study (2012) (0)
Long-Term Safety and Efficacy of Recombinant Human Parathyroid Hormone (1-84) in Adults With Chronic Hypoparathyroidism (2023) (0)
Abstracts of The Japanese Journal of Nephrology (1980) (0)
The mechanisms of tumoral hypercalcemia—Evidence from diphosphonate treatment (1986) (0)
The increasing understanding of FGF23 in pathogenesis and treatment of diverse endocrine disease (2015) (0)
Studies on the in vitro calcification of porcine xenograft valves and its prevention (1984) (0)
Is Bone Scanning useful in Spinal Osteoporosis (1985) (0)
Central adiposity influences the relationship between 25(OH)D and indices of plasma insulin (37.7) (2014) (0)
Medical management of primary hyperparathyroidism (PHP) (2006) (0)
Treatment of osteoporosis with salmon calcitonin (1986) (0)
Phosphate Metabolism in Health and Disease (2020) (0)
Comparison of the Biological Activity of 25OHD3 and 24, 25(OH)2D3 (1984) (0)
EFFECT OF GLYCINE ON URINARY RISK FACTORS OF KIDNEY STONE DISEASE (1989) (0)
1,25(0H)2D3 RECEPTOR LEVELS IN PERIPHERAL BLOOD MONONUCLEAR CELLS OF PATIENTS WITH POSTMENOPAUSAL OSTEOPOROSIS (1991) (0)
Dose response study of soy isoflavones on bone resorption in postmenopausal women. (2004) (0)
Calcium kinetics in an obese adolescent boy on two levels of calcium intake (2012) (0)
Bone density observations in adolescents consuming a low calcium diet (2011) (0)
Twenty‐Four‐Hour Urine Phosphorus is Highly Variable in Patients with Moderate Chronic Kidney Disease on a Controlled Phosphorus Intake (2017) (0)
Effects of stopping bisphosphonate treatment on height, weight, BMD and bone turnover in children with Osteogenesis Imperfecta (OI) (2007) (0)
Immunoradiometric and two-site assay of human parathyroid hormone (1976) (0)
Purification of human vitamin D-binding protein using reverse phase high pressure liquid chromatography (1983) (0)
Failure of 1,25(OH)2D production in patients with femoral neck fracture (1985) (0)
Changes in calcium accretion in females during adolescence (1996) (0)
Calcium intakes for optimal accretion during adolescence (1996) (0)
Radiographic changes in the femoral endosteal surface associate with increased bone turnover, decreased cortical width, and low bone density (2006) (0)
Serum 25-hydroxyvitamin D and intact parathyroid hormone influences muscle outcomes in children and adolescents (2019) (0)
Effect of Oral 25 Hydroxyvitamin D, on Calciun Arsorption and Plasma 1,25 Dihydroxy-Vitamin D in Corticosteroid Treated Subjects (1982) (0)
Effect ofintestinal surgeryon therisk ofurinary stoneformation (1981) (0)
The effect of antithyroid drugs on calcium metabolism in thyrotoxicosis (1983) (0)
Is progestogen superior to estrogen for the treatment of postmenopausal bone loss (1986) (0)
Vitamin D in the Treatment of the Hypomagnesaemia of Short Bowel Syndrome (1982) (0)
VITAMIN D THERAPY (1977) (0)
Treatment of Urinary Tract Stone Disease (1980) (0)
Turnover : Six-Year Results of a Phase 2 Clinical Trial Effect of Denosumab on Bone Mineral Density and Biochemical Markers of Bone (2011) (0)
The Effect of Renal Function on Calcium Metabolism in Elderly Women (1982) (0)
The effect of early pregnancy on mineral homeostasis and bone histology (1985) (0)
Changes in bone histology in paget's disease after short-term treatment with etidronate (1985) (0)
Use of calcium isotope tracers for screening potential treatments for osteoporosis (2013) (0)
Early effects of sex steroids on calcium metabolism (1983) (0)
Phosphate and 1alpha-hydroxyvitamin D3 therapy in haemodialysis patients. (1977) (0)
Long-term urinary acidification in phosphatic urolithiasis. (1987) (0)
MUSCLE ENDURANCE AND RECOVERABILITY WITH AGING: RELATIONSHIP TO THE RISK OF FALLING IN OLDER WOMEN: 1310 (1995) (0)
Erratum: Sibling pair linkage and association studies between bone mineral density and the insulin-like growth factor I gene locus (Journal of Clinical Endocrinology and Metabolism 84 (4467-4471)) (2000) (0)
Measurement of plasma 1 25 di hydroxy vitamin d by protein binding assay and radio immunoassay (1979) (0)
Effect of vitamin D supplementation on calcium absorption and retention in adolescent girls (2009) (0)
ASBMR 25th Annual Meeting SA001–SA483 (2003) (0)
Short term high doses of etidronate in Paget's disease. (1986) (0)
VitaminD resistant hypophosphatemic osteomalacia : treatment with 1α-hydroxy vitamin D_3 (1977) (0)
Plasma 1,25 dihydroxy vitamin D in relation to oral 1,25 dihydroxy vitamin D, calcium and phosphate intake, parathyroid hormone and oestrogen treatment (1979) (0)
ASBMR 27th Annual Meeting M001–M525 (2011) (0)
Vitamin D status and calcium metabolism in adolescent black and white girls on a range of controlled calcium intakes (Journal of Clinical Endocrinology and Metabolsim (2008) 93, (3907-3914)) (2009) (0)
ASBMR 30th Annual Meeting WG1–WG41 (2011) (0)
Uterine prolapse and urinary tract obstruction. (1984) (0)
THE EFFECT O F PARATHYROID HORMONE ON THE UPTAKE AND RELEASE O F CALCIUM BY BONE I N TISSUE CULTURE (2012) (0)
Is There a Defect in Calcium Absorption in Homocystinuria (1983) (0)
Prophylactic 1alpha-hydroxyvitamin D3 therapy in haemodialysis patients. (1977) (0)
Regulation of Plasma 1,25-Dihydroxy Cholecalciferol in Primary Hyperparathyroid Patients (1980) (0)
Hyperparathyroidism: A Perspective for the 21st Century Summary Statement from a Workshop on Asymptomatic Primary (2002) (0)
Relationships between bone formation and resorption measured by calcium kinetics and balance and by biochemical markers during adolescent growth (2006) (0)
Vitamin D supplementation in healthy adolescents does not increase calcium absorption (2013) (0)
Calcimimetics in the management of hyperparathyroidism (2007) (0)
Influence of habitual diet and physical activity on determining calcium retention in adolescent boys (2007) (0)
Interpretation of Genetic Linkage Findings (2003) (0)
Prolonged subcutaneous infusion of calcitonin in osteoporosis (1986) (0)
Temporal Changes in Urinary Risk Factors Following Renal Colic (1985) (0)
Asymptomatic primary hyperparathyroidism: to treat or not to treat? (2006) (0)
The Duration of Action of Calcitonin in Osteoporosis (1985) (0)
Cinacalcet reduces serum calcium in intractable primary hyperparathyroidism (PHPT) (2008) (0)
Vitamin D and the Hypercalciuria of Idiopathic Urinary Calcium Stone Disease (1982) (0)
Carcinoma of the Prostate, Sex Steroids and Bone (1984) (0)
P9. The microanatomy of trabecular bone in femoral neck fracture (1989) (0)
Reply to TB Drüeke and B Lacour (2006) (0)
Efficacy and Safety Following 4 Monthly s.c. Doses of a Human Anti-Fibroblast Growth Factor 23 Antibody (KRN23) in Adults with X-linked Hypophosphatemia (2014) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Munro Peacock?

Munro Peacock is affiliated with the following schools:

Munro Peacock's Academic­Influence.com Rankings

Munro Peacock's Degrees

Why Is Munro Peacock Influential?

Munro Peacock's Published Works

Published Works

What Schools Are Affiliated With Munro Peacock?

Munro Peacock's AcademicInfluence.com Rankings